Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News Analysis
Nature Reviews Drug Discovery 3, 899–900 (1 November 2004) | doi:10.1038/nrd1560
Vioxx risk could signify trouble in class
Abstract
Leading researchers in the field answer the question that everyone is asking about COX2 inhibitors.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
